Daiwa Securities Group Inc. Bio N Tech Se Transaction History
Daiwa Securities Group Inc.
- $23.7 Billion
- Q1 2025
A detailed history of Daiwa Securities Group Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 1,915 shares of BNTX stock, worth $212,565. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,915
Previous 1,938
1.19%
Holding current value
$212,565
Previous $221,000
21.27%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BNTX
# of Institutions
336Shares Held
40.5MCall Options Held
1.53MPut Options Held
1.43M-
Baillie Gifford & CO8.04MShares$892 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$470 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$444 Million0.35% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$201 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...